6 results on '"M, Araneta"'
Search Results
2. Contrasting interspecies efficacy and toxicology of 1, 2 -diethy 1–3 -hydroxypyridin-4-one, CP9 4, relates to differing metabolism of the iron chelating site
- Author
-
KP Hoyes, S. Singh, C. Barra, John B. Porter, Paul S. Dobbin, Gary M. Brittenham, Robert C. Hider, E. R. Huehns, M. P. Blackwell, PN Brooks, M. Araneta, and R. D. Abeysinghe
- Subjects
medicine.medical_specialty ,Metabolite ,Glucuronidation ,Hematology ,Metabolism ,Urine ,Biology ,Toxicology ,Guinea pig ,chemistry.chemical_compound ,Endocrinology ,chemistry ,Pharmacokinetics ,Internal medicine ,Toxicity ,medicine ,Glucuronide - Abstract
Summary. In order to define a predictive animal model for the effects of hydroxypyridinone (HPO) iron chelators in humans, we have compared the 28 d oral efficacy and toxicology of the HPO, 1,2-diethyI-3–hydroxypyridin-4–one (CP94) in rats and guinea-pigs and related the results to the contrasting metabolism of this compound in the two species. CP94 was highly effective at mobilizing liver iron in rats but showed toxicity at higher doses, whereas in the guinea-pig the compound lacked toxicity but was ineffective at mobilizing liver iron. These differences can be explained by the contrasting metabolism of the drug between the two species. In rats, at the top dose of 300 mg/kg intragastrically, all animals died before the end of the study, with no deaths or weight loss at lower doses. At 100 mg/kg, rat liver non-haem iron concentrations were reduced by 53% and 44% in females and males respectively (P
- Published
- 1993
- Full Text
- View/download PDF
3. Contrasting interspecies efficacy and toxicology of 1,2-diethyl-3-hydroxypyridin-4-one, CP94, relates to differing metabolism of the iron chelating site
- Author
-
J B, Porter, R D, Abeysinghe, K P, Hoyes, C, Barra, E R, Huehns, P N, Brooks, M P, Blackwell, M, Araneta, G, Brittenham, and S, Singh
- Subjects
Male ,Rats, Sprague-Dawley ,Dose-Response Relationship, Drug ,Species Specificity ,Pyridones ,Iron ,Ferritins ,Guinea Pigs ,Animals ,Female ,Iron Chelating Agents ,Rats - Abstract
In order to define a predictive animal model for the effects of hydroxypyridinone (HPO) iron chelators in humans, we have compared the 28 d oral efficacy and toxicology of the HPO, 1,2-diethyl-3-hydroxypyridin-4-one (CP94) in rats and guinea-pigs and related the results to the contrasting metabolism of this compound in the two species. CP94 was highly effective at mobilizing liver iron in rats but showed toxicity at higher doses, whereas in the guinea-pig the compound lacked toxicity but was ineffective at mobilizing liver iron. These differences can be explained by the contrasting metabolism of the drug between the two species. In rats, at the top dose of 300 mg/kg intragastrically, all animals died before the end of the study, with no deaths or weight loss at lower doses. At 100 mg/kg, rat liver non-haem iron concentrations were reduced by 53% and 44% in females and males respectively (P0.001). At this dose, adrenal medullary cell vacuolation, increased mammary secretory activity, vacuolation of corpora luteal cells and single cell hepatocyte necrosis were seen. There were no reductions in the white cell count. At 50 mg/kg rat liver non-haem iron concentrations were decreased by 50% and 34% in females and males respectively (P0.02). In female rats this was associated with increased mammary secretory activity. In iron-overloaded rats given 100 mg/kg by gavage for 28 d, liver non-haem iron concentration was reduced by 39% (P0.01) and serum ferritin by 71% (P0.001). Ovarian and mammary changes were not influenced by iron loading. In guinea-pigs, CP94 was evaluated at 50 mg/kg, 100 mg/kg or 200 mg/kg by oral insufflation for 28 d. No reduction in liver iron was seen and no systematic dose related histological, biochemical or haematological effects were observed. Whereas in guinea-pigs 99% of urinary recovery following an oral dose of CP94 (100 mg/kg) was as the inactive glucuronide metabolite, in the rat only 23% of the dose was excreted in the urine as the glucuronide with remainder as the free drug or an iron binding metabolite. The lack of both efficacy and toxicity in the guinea-pig may therefore be explained by the rapid inactivation of CP94 by glucuronidation. This metabolism of CP94 in the guinea-pig is closer to humans than the rat, suggesting that both the efficacy and toxicity of this compound in humans may also be limited by glucuronidation.
- Published
- 1993
4. The association of IFI27 expression and fatigue intensification during localized radiation therapy: implication of a para-inflammatory bystander response.
- Author
-
Hsiao CP, Araneta M, Wang XM, and Saligan LN
- Subjects
- Aged, Bystander Effect radiation effects, Case-Control Studies, Humans, Inflammation Mediators metabolism, Male, Membrane Proteins metabolism, Middle Aged, Oligonucleotide Array Sequence Analysis, Prostatic Neoplasms genetics, Transcriptome radiation effects, Fatigue genetics, Membrane Proteins genetics, Prostatic Neoplasms radiotherapy, Radiation Injuries genetics
- Abstract
The mechanisms behind fatigue intensification during cancer therapy remain elusive. The interferon alpha-inducible protein 27 (IFI27) was the most up-regulated gene based on our previous microarray data in fatigued men with non-metastatic prostate cancer receiving localized external beam radiation therapy (EBRT). The purpose of this study was to confirm the IFI27 up-regulation and determine its association with fatigue intensification during EBRT. Peripheral blood samples and fatigue scores were collected at three time points--prior to EBRT, at midpoint, and at completion of EBRT. Confirmatory quantitative real time polymerase chain reaction (qPCR) and enzyme-linked immunosorbent assay (ELISA) were utilized to verify the microarray results. Subjects were a total of 40 Caucasian men with prostate cancer; 20 scheduled for EBRT (65.6 ± 7.5 years old), and 20 on active surveillance as controls (62.8 ± 6.1 years old). Significant IFI27 expression overtime during EBRT was confirmed by qPCR (p < 0.5), which correlated with fatigue scores during EBRT (R = -0.90, p = 0.006). Alterations in mechanisms associated with immune response and mitochondrial function that explain the up-regulation of IFI27 may provide an understanding of the pathways related to the intensification of fatigue during localized radiation therapy.
- Published
- 2013
- Full Text
- View/download PDF
5. Validation of a PCR-based method for the detection of various rendered materials in feedstuffs using a forensic DNA extraction kit.
- Author
-
Myers MJ, Yancy HF, Araneta M, Armour J, Derr J, Hoostelaere LA, Farmer D, Jackson F, Kiessling WM, Koch H, Lin H, Liu Y, Mowlds G, Pinero D, Riter KL, Sedwick J, Shen Y, Wetherington J, and Younkins R
- Subjects
- Animals, Cattle, DNA Primers, Encephalopathy, Bovine Spongiform prevention & control, Encephalopathy, Bovine Spongiform transmission, False Positive Reactions, Humans, Sensitivity and Specificity, Sheep, Species Specificity, Swine, Time Factors, Animal Feed analysis, DNA analysis, Food Contamination analysis, Laboratories standards, Polymerase Chain Reaction methods
- Abstract
A method trial was initiated to validate the use of a commercial DNA forensic kit to extract DNA from animal feed as part of a PCR-based method. Four different PCR primer pairs (one bovine pair, one porcine pair, one ovine primer pair, and one multispecies pair) were also evaluated. Each laboratory was required to analyze a total of 120 dairy feed samples either not fortified (control, true negative) or fortified with bovine meat and bone meal, porcine meat and bone meal (PMBM), or lamb meal. Feeds were fortified with the animal meals at a concentration of 0.1% (wt/wt). Ten laboratories participated in this trial, and each laboratory was required to evaluate two different primer pairs, i.e., each PCR primer pair was evaluated by five different laboratories. The method was considered to be validated for a given animal source when three or more laboratories achieved at least 97% accuracy (29 correct of 30 samples for 96.7% accuracy, rounded up to 97%) in detecting the fortified samples for that source. Using this criterion, the method was validated for the bovine primer because three laboratories met the criterion, with an average accuracy of 98.9%. The average false-positive rate was 3.0% in these laboratories. A fourth laboratory was 80% accurate in identifying the samples fortified with bovine meat and bone meal. A fifth laboratory was not able to consistently extract the DNA from the feed samples and did not achieve the criterion for accuracy for either the bovine or multispecies PCR primers. For the porcine primers, the method was validated, with four laboratories meeting the criterion for accuracy with an average accuracy of 99.2%. The fifth laboratory had a 93.3% accuracy outcome for the porcine primer. Collectively, these five laboratories had a 1.3% false-positive rate for the porcine primer. No laboratory was able to meet the criterion for accuracy with the ovine primers, most likely because of problems with the synthesis of the primer pair; none of the positive control DNA samples could be detected with the ovine primers. The multispecies primer pair was validated in three laboratories for use with bovine meat and bone meal and lamb meal but not with PMBM. The three laboratories had an average accuracy of 98.9% for bovine meat and bone meal, 97.8% for lamb meal, and 63.3% for PMBM. When examined on an individual laboratory basis, one of these four laboratories could not identify a single feed sample containing PMBM by using the multispecies primer, whereas the other laboratory identified only one PMBM-fortified sample, suggesting that the limit of detection for PMBM with this primer pair is around 0.1% (wt/wt). The results of this study demonstrated that the DNA forensic kit can be used to extract DNA from animal feed, which can then be used for PCR analysis to detect animal-derived protein present in the feed sample.
- Published
- 2006
- Full Text
- View/download PDF
6. Benign osteoblastoma of the mandible: report of a case.
- Author
-
Haug RH, Hauer C, De Camillo AJ, and Araneta M
- Subjects
- Adult, Diagnosis, Differential, Female, Humans, Mandibular Neoplasms diagnosis, Osteoma, Osteoid diagnosis, Mandibular Neoplasms pathology, Osteoma, Osteoid pathology
- Published
- 1990
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.